Yigit Ece, Yasar Serdar, Can Meryem, Bayraktar Zeki
Department of Internal Medicine, İstanbul Medipol University Faculty of Medicine, İstanbul, Türkiye.
Department of Emergency Medicine, İstanbul Medipol University Faculty of Medicine, İstanbul, Türkiye.
Arch Rheumatol. 2024 Aug 24;39(3):393-403. doi: 10.46497/ArchRheumatol.2024.10486. eCollection 2024 Sep.
The study aimed to compare gout patients and healthy subjects in terms of erectile dysfunction, carotid intima-media thickness (CIMT), and other variables and to investigate the relationship between CIMT and erectile dysfunction.
This cross-sectional study was conducted with 134 male gout patients (median age: 56 years; range, 48 to 62 years) and 104 healthy males (median age: 47 years; range, 40.5 to 54.5 years) between September 2022 and June 2023. Age, comorbidities, height, weight, laboratory results, gout treatment data, insulin resistance evaluated by the homeostatic model assessment for insulin resistance, presence and severity of erectile dysfunction evaluated by the six-item International Index of Erectile Function erectile function domain (IIEF-EF), and CIMT measured by ultrasound were assessed.
Hypertension, hyperlipidemia, greater insulin resistance, erectile dysfunction, and bilaterally increased CIMT were significantly more common in the gout group. The mean IIEF-EF score of gout patients was significantly lower than that of controls. Multivariable logistic regression revealed increased CIMT as the sole parameter independently associated with erectile dysfunction (p=0.010). When both groups were categorized into CIMT-based subsets, erectile dysfunction was present in 97.9% of patients with coexistence of gout and increased CIMT (≥0.9 mm), a significantly higher proportion compared to the other three subsets (p<0.001).
Increased CIMT was the only factor independently associated with a greater likelihood of erectile dysfunction in patients with and without gout; however, coexistence of gout and increased CIMT appears to result in a significantly elevated risk for erectile dysfunction.
本研究旨在比较痛风患者和健康受试者在勃起功能障碍、颈动脉内膜中层厚度(CIMT)及其他变量方面的差异,并探究CIMT与勃起功能障碍之间的关系。
本横断面研究于2022年9月至2023年6月期间,对134例男性痛风患者(中位年龄:56岁;范围48至62岁)和104例健康男性(中位年龄:47岁;范围40.5至54.5岁)进行。评估了年龄、合并症、身高、体重、实验室检查结果、痛风治疗数据、通过稳态模型评估胰岛素抵抗来评估的胰岛素抵抗、通过国际勃起功能指数六项勃起功能领域(IIEF-EF)评估的勃起功能障碍的存在及严重程度,以及通过超声测量的CIMT。
痛风组中高血压、高脂血症、更高的胰岛素抵抗、勃起功能障碍以及双侧CIMT增加显著更为常见。痛风患者的平均IIEF-EF评分显著低于对照组。多变量逻辑回归显示,CIMT增加是与勃起功能障碍独立相关的唯一参数(p = 0.010)。当两组根据CIMT分为不同亚组时,痛风与CIMT增加(≥0.9 mm)并存的患者中97.9%存在勃起功能障碍,这一比例显著高于其他三个亚组(p < 0.001)。
CIMT增加是痛风患者和非痛风患者中与勃起功能障碍可能性增加独立相关的唯一因素;然而,痛风与CIMT增加并存似乎会导致勃起功能障碍的风险显著升高。